首页|期刊导航|Virologica Sinica|Development of an HSV-1 F strain BAC system using the synthetic platform

Development of an HSV-1 F strain BAC system using the synthetic platformOA

中文摘要

Dear Editor,Herpes simplex virus type 1(HSV-1)is a large double-stranded DNA virus capable of establishing infections at diverse anatomical sites including the ocular mucosa,orofacial epithelium,genital tract,and neural tissue.As a globally prevalent human pathogen,sustained research on HSV-1 has driven advances in related therapies and basic virology.Moreover,HSV-1 exhibits significant oncolytic potency as an anti-tumor therapeutic vector(Russell et al.,2012).

Qiran Yin;Han Xiao;Hengrui Hu;Jiang Li;Manli Wang;Zhihong Hu

State Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China University of Chinese Academy of Sciences,Beijing,100049,ChinaState Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,ChinaState Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,ChinaState Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,ChinaState Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,ChinaState Key Laboratory of Virology and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China

医药卫生

HSVoncolytic virussynthetic biologybac systemtherapeutic vector

《Virologica Sinica》 2026 (2)

P.478-481,4

supported by grant from the National Key R&D Program of China(2023YFC2306600).

10.1016/j.virs.2026.03.003

评论